Evolus (EOLS) Invested Capital (2017 - 2026)
Evolus (EOLS) reported Invested Capital of $127.6 million for Q1 2026, up 10.79% on a YoY basis from $115.2 million in Q1 2025, and up 3.78% quarter-over-quarter from $123.0 million in Q4 2025.
Evolus (EOLS) Invested Capital (2017 - 2026) Analysis & Trends
Evolus has reported Invested Capital for 10 years, with the latest figure at $127.6 million in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital rose 10.79% year-over-year to $127.6 million; the trailing twelve-month figure through Mar 2026 stood at $127.6 million (up 10.79% YoY), and the FY2025 full-year result was $123.0 million, down 3.18% from the prior year.
- Invested Capital for Q1 2026 stood at $127.6 million, up from $123.0 million in the prior quarter.
- The five-year high for Invested Capital was $140.2 million in Q2 2024, with the low at -$28.8 million in Q3 2025.
- Historically, Invested Capital has averaged $77.4 million across 5 years, with a median of $86.1 million in 2022.
- Annual changes were most pronounced in 2024 — Invested Capital jumped 718.95% — and 2025, when it slumped 122.63%.
- Evolus' Invested Capital stood at $58.3 million in 2022, then tumbled by 73.42% to $15.5 million in 2023, then jumped by 718.95% to $127.0 million in 2024, then declined by 3.18% to $123.0 million in 2025, then advanced by 3.78% to $127.6 million in 2026.
- The last three Invested Capital figures came in at $127.6 million (Q1 2026), $123.0 million (Q4 2025), and -$28.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 10.84 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 3.41 Bn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 373.23 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 10.24 Bn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 1.78 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1.79 Bn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 108.58 Mn |
| 10 | Evolus | 438.71 Mn | 388.91 Mn | 48.90 Mn | 127.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.63 Mn |
| Dec 31, 2025 | 122.99 Mn |
| Sep 30, 2025 | -28.76 Mn |
| Jun 30, 2025 | -18.65 Mn |
| Mar 31, 2025 | 115.20 Mn |
| Dec 31, 2024 | 127.03 Mn |
| Sep 30, 2024 | 127.10 Mn |
| Jun 30, 2024 | 140.23 Mn |
| Mar 31, 2024 | 139.08 Mn |
| Dec 31, 2023 | 15.51 Mn |
| Sep 30, 2023 | 19.33 Mn |
| Jun 30, 2023 | 32.14 Mn |
| Mar 31, 2023 | 46.55 Mn |
| Dec 31, 2022 | 58.35 Mn |
| Sep 30, 2022 | 68.22 Mn |
| Jun 30, 2022 | 86.06 Mn |
| Mar 31, 2022 | 138.63 Mn |
| Dec 31, 2021 | 121.30 Mn |
| Sep 30, 2021 | 136.40 Mn |
| Jun 30, 2021 | 144.84 Mn |